BAM
AVNS

Byrne Asset Management’s Avanos Medical AVNS Stock Holding History

Byrne Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-100
Closed -$3K – 583
2023
Q1 		$3K Buy
+100
New +$2.9K ﹤0.01% 487
2022
Q2 		– Sell
-12
Closed – – 515
2022
Q1 		$0 Hold
12
– – ﹤0.01% 526
2021
Q4 		$0 Buy
+12
New +$388 ﹤0.01% 524

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Byrne Asset Management's AVNS Position: Q2 2023 in Review

Byrne Asset Management sold out of Avanos Medical (AVNS) in Q2 2023, closing a stake of 100 shares — an estimated $3K sold.

Byrne Asset Management first reported a position in AVNS in Q4 2021 and held it in 3 quarters. The position peaked at $3K in Q1 2023. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2023.

  • Byrne Asset Management reported no remaining Avanos Medical position as of Q2 2023 after selling out during the quarter.
  • Byrne Asset Management sold 100 Avanos Medical shares in Q2 2023, an estimated $3K.
  • Byrne Asset Management first reported a position in Avanos Medical in Q4 2021 and held it in 3 quarters.
  • Byrne Asset Management's Avanos Medical position peaked at $3K in Q1 2023.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2023.

Based on Byrne Asset Management's 13F filing for Q2 2023, filed 21 Jul 2023.